NotizieAssistito da IA

Lifecore Appoints Legal Veteran Tom Salus to Executive Team

Tom Salus joins Lifecore as Chief Legal Officer, enhancing leadership in compliance and strategy.

Priyanka Patil
Di Priyanka Patil
Collaboratore marketing · Pharma Now
15 apr 2025Updated Jun 26, 2025 · 2 min di lettura
Lifecore Appoints Legal Veteran Tom Salus to Executive Team
https://www.linkedin.com/in/tom-salus-2aa1bb6/
Giornalismo assistito da IA
Reviewed by Priyanka Patil, Collaboratore marketing · Pharma Now

Lifecore Biomedical, Inc. (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), announced the appointment of Thomas (Tom) Salus as Chief Legal and Administration Officer and Corporate Secretary. With more than 30 years of legal and management experience, Salus brings expertise in corporate governance, SEC reporting and compliance, business transactions, financings, and regulatory compliance.

At Lifecore, Salus will oversee all legal activities and human resources, while playing a key role in strategy development and corporate initiatives focused on partnerships and strategic alliances.

Prior to joining Lifecore, Salus served as General Counsel – Corporate, Securities & Transactions and Assistant Secretary at Viatris Inc., a Nasdaq-listed global pharmaceutical company. His responsibilities included legal support for global business development, complex transactions, and SEC/Nasdaq compliance. He has also held legal leadership roles at VWR International (now part of Avantor, Inc.) and PPL Corporation, and began his legal career at firms including Faegre Drinker Biddle & Reath LLP.

Lifecore President and CEO Paul Josephs said that Salus’s appointment strengthens the company’s leadership team and enhances internal capabilities in governance and compliance. He noted Salus’s deep experience in the life sciences industry and strategic insight as important assets for the company’s growth.

Salus said he is excited to join the team, highlighting Lifecore’s recent progress in reshaping the company and executing on its growth strategy. He emphasized the unique position Lifecore holds as the only publicly listed, pure-play CDMO and expressed enthusiasm about contributing to its continued success.

ArgomentiNews
Priyanka Patil
Written by
Priyanka Patil
Collaboratore marketing · Pharma Now

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Caricamento della discussione…

Altro da Pharma News

Tutti gli articoli →